98 related articles for article (PubMed ID: 24673720)
21. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
Prabhu N; Prabakaran M; Hongliang Q; He F; Ho HT; Qiang J; Goutama M; Lim AP; Hanson BJ; Kwang J
Antivir Ther; 2009; 14(7):911-21. PubMed ID: 19918095
[TBL] [Abstract][Full Text] [Related]
22. Suboptimal protection against H5N1 highly pathogenic avian influenza viruses from Vietnam in ducks vaccinated with commercial poultry vaccines.
Cha RM; Smith D; Shepherd E; Davis CT; Donis R; Nguyen T; Nguyen HD; Do HT; Inui K; Suarez DL; Swayne DE; Pantin-Jackwood M
Vaccine; 2013 Oct; 31(43):4953-60. PubMed ID: 23994373
[TBL] [Abstract][Full Text] [Related]
23. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
[TBL] [Abstract][Full Text] [Related]
24. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
Kreijtz JH; Bodewes R; van den Brand JM; de Mutsert G; Baas C; van Amerongen G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Vaccine; 2009 Aug; 27(36):4983-9. PubMed ID: 19538996
[TBL] [Abstract][Full Text] [Related]
25. Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine.
Cagle C; To TL; Nguyen T; Wasilenko J; Adams SC; Cardona CJ; Spackman E; Suarez DL; Pantin-Jackwood MJ
Vaccine; 2011 Sep; 29(38):6549-57. PubMed ID: 21771626
[TBL] [Abstract][Full Text] [Related]
26. Distribution of avian influenza H5N1 viral RNA in tissues of AI-vaccinated and unvaccinated contact chickens after experimental infection.
Hassan MK; Kilany WH; Abdelwhab EM; Arafa AS; Selim A; Samy A; Samir M; Le Brun Y; Jobre Y; Aly MM
Arch Virol; 2012 May; 157(5):951-9. PubMed ID: 22350650
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotide.
Duan M; Zhou Z; Lin RX; Yang J; Xia XZ; Wang SQ
Antivir Ther; 2008; 13(1):109-14. PubMed ID: 18389905
[TBL] [Abstract][Full Text] [Related]
28. Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein.
Wang SF; Chen KH; Thitithanyanont A; Yao L; Lee YM; Chan YJ; Liu SJ; Chong P; Liu WT; Huang JC; Chen YM
Biochem Biophys Res Commun; 2009 May; 382(4):691-6. PubMed ID: 19327345
[TBL] [Abstract][Full Text] [Related]
29. Isolation of recombinant phage antibodies targeting the hemagglutinin cleavage site of highly pathogenic avian influenza virus.
Dong J; Sakurai A; Nomura N; Park EY; Shibasaki F; Ueda H
PLoS One; 2013; 8(4):e61158. PubMed ID: 23577205
[TBL] [Abstract][Full Text] [Related]
30. Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.
He F; Prabakaran M; Rajesh Kumar S; Tan Y; Kwang J
Antiviral Res; 2014 May; 105():143-51. PubMed ID: 24637255
[TBL] [Abstract][Full Text] [Related]
31. Cross-clade protection against HPAI H5N1 influenza virus challenge in BALB/c mice intranasally administered adjuvant-combined influenza vaccine.
Yang P; Tang C; Luo D; Zhan Z; Xing L; Duan Y; Jia W; Peng D; Liu X; Wang X
Vet Microbiol; 2010 Nov; 146(1-2):17-23. PubMed ID: 20888151
[TBL] [Abstract][Full Text] [Related]
32. Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004.
Jadhao SJ; Nguyen DC; Uyeki TM; Shaw M; Maines T; Rowe T; Smith C; Huynh LP; Nghiem HK; Nguyen DH; Nguyen HK; Nguyen HH; Hoang LT; Nguyen T; Phuong LS; Klimov A; Tumpey TM; Cox NJ; Donis RO; Matsuoka Y; Katz JM
Arch Virol; 2009; 154(8):1249-61. PubMed ID: 19578928
[TBL] [Abstract][Full Text] [Related]
33. A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmission.
Wu R; Li X; Leung HC; Cao Z; Qiu Z; Zhou Y; Zheng BJ; He Y
Antiviral Res; 2014 Jun; 106():13-23. PubMed ID: 24681124
[TBL] [Abstract][Full Text] [Related]
34. Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease.
Wang H; Wong G; Zhu W; He S; Zhao Y; Yan F; Rahim MN; Bi Y; Zhang Z; Cheng K; Jin H; Cao Z; Zheng X; Gai W; Bai J; Chen W; Zou Y; Gao Y; Gao GF; Yang S; Xia X; Qiu X
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541860
[TBL] [Abstract][Full Text] [Related]
35. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.
Gao W; Soloff AC; Lu X; Montecalvo A; Nguyen DC; Matsuoka Y; Robbins PD; Swayne DE; Donis RO; Katz JM; Barratt-Boyes SM; Gambotto A
J Virol; 2006 Feb; 80(4):1959-64. PubMed ID: 16439551
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a highly pathogenic avian influenza H5N1 virus isolated from an ostrich.
Yang P; Dongmei ; Wang C; Tang C; Xing L; Luo D; Zhan Z; Duan Y; Jia W; Peng D; Liu X; Wang X
Biochem Biophys Res Commun; 2010 Jun; 396(4):973-7. PubMed ID: 20497905
[TBL] [Abstract][Full Text] [Related]
37. Influenza vaccines and vaccination strategies in birds.
van den Berg T; Lambrecht B; Marché S; Steensels M; Van Borm S; Bublot M
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):121-65. PubMed ID: 17889937
[TBL] [Abstract][Full Text] [Related]
38. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
39. Production and characterization of monoclonal antibodies against NS1 protein of H5N1 avian influenza virus.
Rai M; Bhatia S; Malik YP; Dubey SC
Hybridoma (Larchmt); 2010 Apr; 29(2):183-6. PubMed ID: 20443713
[TBL] [Abstract][Full Text] [Related]
40. Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants.
Prabakaran M; Prabhu N; He F; Hongliang Q; Ho HT; Qiang J; Meng T; Goutama M; Kwang J
PLoS One; 2009 May; 4(5):e5672. PubMed ID: 19478856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
